Related Experiment Video
Updated: Jan 31, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for
Younho Choi1, Su-Jin Park2, Yinyan Sun3
1Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Zilkha Neurogenetic Institute, Los Angeles, CA, USA.
Abstract:
Severe fever with thrombocytopenia syndrome phlebovirus (SFTSV), listed in the World Health Organization Prioritized Pathogens, is an emerging phlebovirus with a high fatality1-4. Owing to the lack of therapies and vaccines5,6, there is a pressing need to understand SFTSV pathogenesis. SFSTV non-structural protein (NSs) has been shown to block type I interferon induction7-11 and facilitate disease progression12,13. Here, we report that SFTSV-NSs targets the tumour progression locus 2 (TPL2)-A20-binding inhibitor of NF-κB activation 2 (ABIN2)-p105 complex to induce the expression of interleukin-10 (IL-10) for viral pathogenesis. Using a combination of reverse genetics, a TPL2 kinase inhibitor and Tpl2-/- mice showed that NSs interacted with ABIN2 and promoted TPL2 complex formation and signalling activity, resulting in the marked upregulation of Il10 expression. Whereas SFTSV infection of wild-type mice led to rapid weight loss and death, Tpl2-/- mice or Il10-/- mice survived an infection. Furthermore, SFTSV-NSs P102A and SFTSV-NSs K211R that lost the ability to induce TPL2 signalling and IL-10 production showed drastically reduced pathogenesis. Remarkably, the exogenous administration of recombinant IL-10 effectively rescued the attenuated pathogenic activity of SFTSV-NSs P102A, resulting in a lethal infection. Our study demonstrates that SFTSV-NSs targets the TPL2 signalling pathway to induce immune-suppressive IL-10 cytokine production as a means to dampen the host defence and promote viral pathogenesis.
Insights
Severe fever with thrombocytopenia syndrome phlebovirus (SFTSV) non-structural protein (NSs) hijacks the TPL2-ABIN2-p105 complex to induce IL-10, promoting viral pathogenesis. Blocking this pathway offers a potential therapeutic target for SFTSV infection.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Severe fever with thrombocytopenia syndrome phlebovirus (SFTSV) is a high-fatality emerging pathogen.
- SFTSV non-structural protein (NSs) is crucial for viral pathogenesis, notably by inhibiting type I interferon induction.
- Understanding SFTSV pathogenesis is critical due to the lack of effective therapies and vaccines.
Purpose of the Study:
- To elucidate the molecular mechanism by which SFTSV NSs contributes to viral pathogenesis.
- To investigate the interaction of SFTSV NSs with host cellular components.
- To identify host pathways targeted by SFTSV NSs for immune evasion and disease progression.
Main Methods:
- Reverse genetics was employed to study SFTSV NSs function.
- A TPL2 kinase inhibitor and Tpl2 knockout mice were used to assess the role of the TPL2 pathway.
- Interleukin-10 (IL-10) expression levels were measured in infected cells and mice.
- Mutant SFTSV strains (NSs P102A, NSs K211R) were generated and analyzed for pathogenicity.
- Recombinant IL-10 was administered to assess its effect on viral pathogenesis.
Main Results:
- SFTSV NSs interacts with A20-binding inhibitor of NF-κB activation 2 (ABIN2) and promotes the formation and signaling activity of the tumour progression locus 2 (TPL2)-ABIN2-p105 complex.
- This interaction leads to the significant upregulation of interleukin-10 (IL-10) expression.
- Tpl2 knockout or IL-10 knockout mice exhibited resistance to SFTSV infection, while wild-type mice succumbed rapidly.
- SFTSV mutants lacking the ability to induce TPL2 signaling and IL-10 production showed reduced pathogenicity.
- Exogenous IL-10 administration restored the pathogenicity of these attenuated mutants.
Conclusions:
- SFTSV NSs targets the TPL2 signaling pathway to induce immunosuppressive IL-10 production.
- This mechanism serves to dampen host immune defense, thereby promoting viral pathogenesis.
- The TPL2-IL-10 axis represents a critical host pathway exploited by SFTSV for survival and disease progression.
- Targeting the TPL2-IL-10 pathway could be a potential therapeutic strategy against SFTSV.
More Related Videos
Related Concept Videos
Viral Structure
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
Non-Canonical Wnt Signaling Pathways

